SCHEMBL9899074

SCHEMBL9899074

C/C(CC(=O)Cc1ccccc1)=N\OS(=O)(=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.42
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 2/20 0.41
MAPK1 P28482 1/20 0.40
EGFR P00533 1/20 0.40
ERBB2 P04626 1/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.39
PRMT1 Q99873 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
HSP90AA1 P07900 1/20 0.38
XBP1 P17861 1/20 0.38
MPI P34949 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
AKR1B1 P15121 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9899076 1.00 MAPT (0.42) MAPTKDM4EALDH1A1KMT2AMAPK1
SCHEMBL2052869 0.87 MAPT (0.41) MAPTKDM4EALDH1A1KMT2AMAPK1
SCHEMBL2052870 0.87 MAPT (0.41) MAPTKDM4EALDH1A1KMT2AMAPK1
SCHEMBL2046621 0.86 MAPT (0.49) MAPTKDM4EALDH1A1KMT2AMAPK1
SCHEMBL2046619 0.86 MAPT (0.49) MAPTKDM4EALDH1A1KMT2AMAPK1
SCHEMBL9898903 0.85 HSD11B1 (0.49) MAPTKDM4EALDH1A1KMT2AMAPK1
SCHEMBL9899267 0.85 MAPT (0.43) MAPTKDM4EALDH1A1KMT2AMAPK1
SCHEMBL9898905 0.85 HSD11B1 (0.49) MAPTKDM4EALDH1A1KMT2AMAPK1
SCHEMBL9899266 0.85 MAPT (0.43) MAPTKDM4EALDH1A1KMT2AMAPK1
SCHEMBL9898283 0.85 MAPT (0.46) MAPTKDM4EALDH1A1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025024507-A1 MELANOGENESIS INHIBITION COMPOSITIONS AND METHODS OF USE THEREOF MDI BIOLOGICAL LABORATORY (US) 2025-01-30 WO claimed
US-8748531-B2 Polymers functionalized with oxime compounds containing an acyl group BRIDGESTONE CORPORATION (JP) 2014-06-10 US claimed
US-20120149833-A1 POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP BRIDGESTONE CORPORATION (JP) 2012-06-14 US claimed
WO-2025024507-A1 MELANOGENESIS INHIBITION COMPOSITIONS AND METHODS OF USE THEREOF MDI BIOLOGICAL LABORATORY (US) 2025-01-30 WO disclosed
EP-2649102-B1 POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP BRIDGESTONE CORP (JP) 2014-11-26 EP disclosed
US-8748531-B2 Polymers functionalized with oxime compounds containing an acyl group BRIDGESTONE CORPORATION (JP) 2014-06-10 US disclosed
EP-2649102-A1 POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP Bridgestone Corporation (JP) 2013-10-16 EP disclosed
US-20120149833-A1 POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP BRIDGESTONE CORPORATION (JP) 2012-06-14 US disclosed
WO-2012078962-A1 POLYMERS FUNCTIONALIZED WITH OXIME COMPOUNDS CONTAINING AN ACYL GROUP BRIDGESTONE CORPORATION (JP) 2012-06-14 WO disclosed